| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 130 |
| 1 | OXALIPLATIN | 63 |
| 2 | FLUOROURACIL | 56 |
| 3 | FLUOROURACIL CREAM, 0.5% | 56 |
| 4 | CAPECITABINE | 45 |
| 5 | ADALIMUMAB | 37 |
| 6 | PACLITAXEL | 37 |
| 7 | CARBOPLATIN | 34 |
| 8 | PREDNISOLONE | 32 |
| 9 | PREDNISOLONE ORAL | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LONAFARNIB | 1 | 0.0128 |
| 1 | ANIDULAFUNGIN | 13 | 0.0080 |
| 2 | ERYTHROMYCIN LACTOBIONATE | 1 | 0.0068 |
| 3 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 2 | 0.0068 |
| 4 | CASPOFUNGIN ACETATE | 10 | 0.0063 |
| 5 | BEVACIZUMAB-ADCD | 1 | 0.0049 |
| 6 | IDARUCIZUMAB | 5 | 0.0035 |
| 7 | BARIUM SULFATE | 1 | 0.0023 |
| 8 | AMPICILLIN AND SULBACTAM | 2 | 0.0023 |
| 9 | LANTHANUM CARBONATE | 11 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 133 |
| 1 | Platinum-based Drug [EPC] | 105 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 104 |
| 3 | Corticosteroid [EPC] | 63 |
| 4 | Microtubule Inhibitor [EPC] | 42 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 42 |
| 6 | Purine Antimetabolite [EPC] | 20 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 20 |
| 8 | Benzodiazepine [EPC] | 18 |
| 9 | Penem Antibacterial [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Farnesyltransferase Inhibitor [EPC] | 1 | 0.0128 |
| 1 | Humanized Monoclonal Antibody Fragment [EPC] | 5 | 0.0035 |
| 2 | Echinocandin Antifungal [EPC] | 13 | 0.0016 |
| 3 | Lipopeptide Antibacterial [EPC] | 13 | 0.0014 |
| 4 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 6 | 0.0012 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 133 | 0.0007 |
| 6 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 7 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 8 | Penem Antibacterial [EPC] | 17 | 0.0005 |
| 9 | Oxazolidinone Antibacterial [EPC] | 15 | 0.0005 |